Phoenix Nest is a niche biotech company based in New York, NY, dedicated to developing treatments for Sanfilippo syndrome, an ultra-rare and untreatable disease. Founded by a group of parents with children suffering from this condition, the company has a strong sense of urgency and determination to bring a curative treatment to affected families.
With the support of grants from the National Institute of Health, Phoenix Nest has been able to facilitate research in academic labs and successfully meet the challenges of pioneering treatments for this rare disease. Guided by an Independent Scientific Advisory Board and a Board of Directors, the company is committed to providing hope and improving the lives of those affected by Sanfilippo syndrome.
Generated from the website